News

The US Food and Drug Administration (FDA) has approved a label update with a new recommended titration dosing schedule for ...
The phase 3 trial evaluated fenfluramine when used as an adjunctive therapy for the treatment of uncontrolled seizures in children and adults aged 1 year to 35 years with CDD.
GLP-1RA use necessitated shifting priorities in nutrition and lifestyle modification among patients with obesity, according ...
India is among the top two countries in terms of type 2 diabetes cases and third in terms of obesity; hence, the need for ...
Danish drugmaker Novo Nordisk is working to bring its blockbuster drug Ozempic to India “as soon as possible", Dr Yan Cai, ...
Analysts said the deal with Novo was likely giving Hims “‘credibility’ or increased consumer traffic,” adding that the ...
After a season of regulatory upheaval, obesity and rare genetic diseases will likely remain major themes for biopharma in ...
DUD DOSE The truth about why Ozempic-like weight loss jabs are FAILING to work for thousands of us – are you one of them?
Luspatercept-aamt shows significant survival benefits and transfusion independence in lower-risk MDS, reshaping treatment ...
A lawsuit says the woman "was brought to the hospital with an altered mental status, restrained and essentially forgotten." ...
I was just a baby scientist when I discovered the hormone that made Ozempic possible. I had no idea how life-changing—and ...
First Orally Active Fatty Acid Binding Protein 5 Inhibitor Evaluated in Humans First-in-Class Approach Targets Unmet Need in Multibillion-Dollar Pain Management Market SOLANA BEACH, Calif., June 30, ...